A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis (clinicaltrials.gov) - Jun 2, 2026 - P3 | N=669 | Recruiting | Sponsor: Haisco Pharmaceutical Group Co., Ltd.
New P3 trial • Bronchiectasis • Genetic Disorders • Immunology • Non‐Cystic Fibrosis Bronchiectasis • Pulmonary Disease • Respiratory Diseases
|